A open label cohort, international, multicentre and investigator initiated study to evaluate the add-on therapy with entecavir plus tenofovir due to viral resistance or partial responses followed by monotherapy in chronic hepatitis B patients.
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2015
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 19 Dec 2015 New trial record